The tumor-associated antigen RHAMM (HMMR/CD168) is expressed by monocyte-derived dendritic cells and presented to T cells

We formerly demonstrated that vaccination with Wilms’ tumor 1 (WT1)-loaded autologous monocyte-derived dendritic cells (mo-DCs) can be a well-tolerated effective treatment in acute myeloid leukemia (AML) patients. Here, we investigated whether we could introduce the receptor for hyaluronic acid-medi...

Descripción completa

Detalles Bibliográficos
Autores principales: Willemen, Yannick, Van den Bergh, Johan M.J., Bonte, Sarah M., Anguille, Sébastien, Heirman, Carlo, Stein, Barbara M.H., Goossens, Herman, Kerre, Tessa, Thielemans, Kris, Peeters, Marc, Van Tendeloo, Viggo F.I., Smits, Evelien L.J., Berneman, Zwi N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342027/
https://www.ncbi.nlm.nih.gov/pubmed/27659531
http://dx.doi.org/10.18632/oncotarget.12170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342027/
https://www.ncbi.nlm.nih.gov/pubmed/27659531
http://dx.doi.org/10.18632/oncotarget.12170

Ejemplares similares